Castle Biosciences, Inc.(CSTL)_个股概要_股票价格_最新资讯_行情走势_历史数据 - 老虎社区

应交易所要求，美/港股行情延时15分钟展示，下载APP即可免费查看实时行情。

关闭

CSTL Castle Biosciences, Inc.

未开盘 03-13 16:00:00 EDT

25.56

+0.24

+0.95%

盘后25.56

+0.000.00%

16:10 EDT

最高26.13	最低25.20	成交量24.55万
今开25.40	昨收25.32	日振幅3.67%
总市值7.60亿	流通市值6.42亿	总股本2,973万
成交额625.73万	换手率0.98%	流通股本2,511万
市净率--	ROE--	每股收益0.00
52周最高--	52周最低--	市盈率--
股息--	股息收益率--	ROA--

数据加载中...

北京优虎网络科技有限公司

{"stockData":{"symbol":"CSTL","market":"US","secType":"STK","nameCN":"Castle Biosciences, Inc.","latestPrice":25.56,"timestamp":1773432000000,"preClose":25.32,"halted":0,"volume":245502,"hourTrading":{"tag":"盘后","latestPrice":25.56,"preClose":25.56,"latestTime":"16:10 EDT","volume":6357,"amount":162484.92,"timestamp":1773432605114,"change":0,"changeRate":0,"amplitude":0},"delay":0,"changeRate":0.009478672985781929,"floatShares":25112700,"shares":29731198,"eps":-0.833436,"marketStatus":"未开盘","change":0.24,"latestTime":"03-13 16:00:00 EDT","open":25.4,"high":26.13,"low":25.2,"amount":6257319.623712,"amplitude":0.03673,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":0,"ttmEps":-0.833436,"tradingStatus":0,"nextMarketStatus":{"tag":"盘前交易","tradingStatus":1,"beginTime":1773648000000},"marketStatusCode":0,"adr":0,"listingDate":1564027200000,"exchange":"NASDAQ","adjPreClose":25.32,"preHourTrading":{"tag":"盘前","latestPrice":25.44,"preClose":25.32,"latestTime":"09:29 EDT","volume":6,"amount":152.64000000000001,"timestamp":1773408541099,"change":0.12,"changeRate":0.004739,"amplitude":0},"postHourTrading":{"tag":"盘后","latestPrice":25.56,"preClose":25.56,"latestTime":"16:10 EDT","volume":6357,"amount":162484.92,"timestamp":1773432605114,"change":0,"changeRate":0,"amplitude":0},"volumeRatio":0.8117351809778515,"impliedVol":0.6769,"impliedVolPercentile":0.7809},"requestUrl":"/m/hq/s/CSTL","defaultTab":"news","newsList":[{"id":"1169218390","title":"Castle Biosciences, Inc. 2025年总营收预期突破3.4亿美元，超越此前3.27亿至3.35亿美元指引区间","url":"https://stock-news.laohu8.com/highlight/detail?id=1169218390","media":"美股速递","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1169218390?lang=zh_cn&edition=full","pubTime":"2026-01-12 05:01","pubTimestamp":1768165314,"startTime":"0","endTime":"0","summary":"Castle Biosciences, Inc.最新预测显示，公司2025年总营收有望突破3.4亿美元大关，显著高于此前公布的3.27亿至3.35亿美元业绩指引上限。这一乐观预期反映出公司核心诊断业务增长动能强劲，市场对其专有基因检测服务的需求持续攀升。随着精准医疗领域加速发展，该企业通过扩大临床验证范围和优化商业布局，正不断巩固其在皮肤癌分子诊断领域的领先地位。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4196","CSTL"],"gpt_icon":0},{"id":"1107669262","title":"系统评估与荟萃分析确认Tissuecypher®在识别食管癌高风险患者方面优于传统病理或单独临床因素","url":"https://stock-news.laohu8.com/highlight/detail?id=1107669262","media":"美股速递","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1107669262?lang=zh_cn&edition=full","pubTime":"2025-12-12 20:00","pubTimestamp":1765540855,"startTime":"0","endTime":"0","summary":"系统评估与荟萃分析确认Tissuecypher®在识别食管癌高风险患者方面优于传统病理或单独临床因素。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4196","CSTL"],"gpt_icon":0},{"id":"1157632361","title":"SciBase与Castle Biosciences扩大合作","url":"https://stock-news.laohu8.com/highlight/detail?id=1157632361","media":"投资观察","labels":["corporation"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1157632361?lang=zh_cn&edition=full","pubTime":"2025-11-20 01:06","pubTimestamp":1763572016,"startTime":"0","endTime":"0","summary":"11月7日（路透社）- SciBase Holding AB（公开）宣布：*SciBase与Castle Biosciences扩大合作并签署许可协议，同时达成2000万瑞典克朗的贷款协议*Castle将向SciBase提供2000万瑞典克朗的贷款。*贷款以对SciBase股份的质押作为担保。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4196","CSTL"],"gpt_icon":0},{"id":"1172425872","title":"新数据确认Decisiondx®-Melanoma在识别淋巴结阳性风险低于5%的患者中的表现","url":"https://stock-news.laohu8.com/highlight/detail?id=1172425872","media":"美股速递","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1172425872?lang=zh_cn&edition=full","pubTime":"2025-11-14 20:01","pubTimestamp":1763121687,"startTime":"0","endTime":"0","summary":"新数据确认Decisiondx®-Melanoma在识别淋巴结阳性风险低于5%的患者中的表现","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4196","CSTL"],"gpt_icon":0},{"id":"1175521487","title":"SciBase与Castle Biosciences扩大合作","url":"https://stock-news.laohu8.com/highlight/detail?id=1175521487","media":"投资观察","labels":["corporation"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1175521487?lang=zh_cn&edition=full","pubTime":"2025-11-07 15:29","pubTimestamp":1762500579,"startTime":"0","endTime":"0","summary":"11月7日 - SciBase Holding AB（上市公司）宣布：*SciBase与Castle Biosciences扩大合作及许可协议，并签订2000万瑞典克朗的贷款协议。*Castle将向SciBase提供2000万瑞典克朗的贷款。*该贷款由SciBase的股票质押作担保。*","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4196","CSTL"],"gpt_icon":0},{"id":"1181352573","title":"Scibase与Castle Biosciences扩大合作与许可协议，并签订2000万瑞典克朗借款协议","url":"https://stock-news.laohu8.com/highlight/detail?id=1181352573","media":"美股速递","labels":["corporation"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1181352573?lang=zh_cn&edition=full","pubTime":"2025-11-07 15:29","pubTimestamp":1762500548,"startTime":"0","endTime":"0","summary":"Scibase与Castle Biosciences扩大合作与许可协议，并签订2000万瑞典克朗借款协议","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["CSTL","BK4196"],"gpt_icon":0},{"id":"1154815250","title":"异动解读 | 分析师上调目标价，Castle Biosciences盘中大涨6%","url":"https://stock-news.laohu8.com/highlight/detail?id=1154815250","media":"异动解读","labels":["movement"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1154815250?lang=zh_cn&edition=full","pubTime":"2025-11-04 22:48","pubTimestamp":1762267696,"startTime":"0","endTime":"0","summary":"Castle Biosciences, Inc.今日盘中股价大涨6%，引发市场关注。这一显著涨幅主要受到华尔街分析师积极评估的推动。据报道，投资银行Leerink Partners上调了对Castle Biosciences的目标股价，从此前的35美元提高至40美元。Castle Biosciences是一家专注于皮肤癌诊断的生物技术公司。分析师目标价的上调通常会被投资者视为积极信号，认为公司的内在价值可能被低估。这种观点的转变促使更多投资者买入该股，从而推动股价上涨。","market":"sg","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"movement","news_rank":0,"length":0,"strategy_id":0,"source":"ai_movement_cn","symbols":["CSTL"],"gpt_icon":0},{"id":"1129464401","title":"SciBase从Castle Biosciences获得临床研究初始订单","url":"https://stock-news.laohu8.com/highlight/detail?id=1129464401","media":"投资观察","labels":["corporation"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1129464401?lang=zh_cn&edition=full","pubTime":"2025-09-23 14:21","pubTimestamp":1758608500,"startTime":"0","endTime":"0","summary":"9月23日 - SciBase Holding AB (publ)从Castle Biosciences获得临床研究初始订单。\n该订单包括Nevisense GO设备和电极，价值约80万美元或约800万瑞典克朗。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4196","CSTL"],"gpt_icon":0},{"id":"2518277687","title":"Castle Biosciences, Inc.盘中异动 股价大跌5.29%","url":"https://stock-news.laohu8.com/highlight/detail?id=2518277687","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2518277687?lang=zh_cn&edition=full","pubTime":"2025-03-10 22:43","pubTimestamp":1741617807,"startTime":"0","endTime":"0","summary":"北京时间2025年03月10日22时43分，Castle Biosciences, Inc.股票出现异动，股价快速下挫5.29%。Castle Biosciences, Inc.股票所在的生命科学行业中，整体跌幅为0.18%。其相关个股中，恩佐生化、Bioaffinity Technologies, Inc.、23Andme Holding Co.涨幅较大，Ispecimen Inc.、Mainz Biomed N.V.、23Andme Holding Co.较为活跃，换手率分别为6.10%、2.68%、1.93%，振幅较大的相关个股有Inotiv, Inc.、23Andme Holding Co.、Exagen Inc.，振幅分别为20.23%、16.77%、15.17%。Castle Biosciences, Inc.公司简介：Castle Biosciences Inc是一家商业阶段的皮肤癌公司。该公司的产品组合包括皮肤黑素瘤，DecisionDx-黑色素瘤，DecisionDx-CMSeq和DecisionDx-PRAME。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025031022432798a2aef2&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025031022432798a2aef2&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["CSTL","BK4196"],"gpt_icon":0},{"id":"2518280964","title":"Castle Biosciences, Inc.2024财年实现净利润18.25百万美元，同比增加131.76%","url":"https://stock-news.laohu8.com/highlight/detail?id=2518280964","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2518280964?lang=zh_cn&edition=full","pubTime":"2025-03-09 00:00","pubTimestamp":1741449618,"startTime":"0","endTime":"0","summary":"3月9日，Castle Biosciences, Inc.公布财报，公告显示公司2024财年净利润为18.25百万美元，同比增加131.76%；其中营业收入为3.32亿美元，同比增加50.91%，每股基本收益为0.66美元。从资产负债表来看，Castle Biosciences, Inc.总负债98.08百万美元，其中短期债务2.04百万美元，资产负债比为0.06，流动比率为0.08。机构评级：截至2025年3月9日，当前有9家机构对Castle Biosciences, Inc.目标价做出预测，其中目标均价为39.67美元，其中最低目标价为36.00美元，最高目标价为44.00美元。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250309000029a266b2b0&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250309000029a266b2b0&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["CSTL"],"gpt_icon":0},{"id":"1158731355","title":"异动解读 | Castle Biosciences股票盘中大涨5.12% 公司财务数据合理","url":"https://stock-news.laohu8.com/highlight/detail?id=1158731355","media":"异动解读","labels":["movement"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1158731355?lang=zh_cn&edition=full","pubTime":"2025-03-05 03:26","pubTimestamp":1741116394,"startTime":"0","endTime":"0","summary":"Castle Biosciences公司股票今日盘中出现较大涨幅,引起了广泛关注。据报道,CSTL股价大涨5.12%,盘中最高达到22.36美元/股,换手率仅1.57%,振幅9.38%,成交量增加。分析人士指出,造成CSTL股价上涨的主要原因可能是公司不久前公布的最新财报数据表现出色。财报显示,CSTL实现营业收入3.32亿美元,净利润1825万美元,每股收益0.66美元,毛利2.59亿美元,市盈率36倍。总的来说,可见CSTL股价上涨与公司自身的业绩表现和融资发展前景密切相关。","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":"异动解读 | Castle Biosciences股票盘中大涨5.12% 公司财务数据合理","news_tag":"movement","news_rank":0,"length":0,"strategy_id":0,"source":"ai_movement_cn","symbols":["CSTL"],"gpt_icon":0},{"id":"2517298864","title":"Castle Biosciences, Inc.盘中异动 股价大涨5.12%报22.36美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2517298864","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2517298864?lang=zh_cn&edition=full","pubTime":"2025-03-05 03:23","pubTimestamp":1741116233,"startTime":"0","endTime":"0","summary":"北京时间2025年03月05日03时23分，Castle Biosciences, Inc.股票出现异动，股价快速上涨5.12%。截至发稿，该股报22.36美元/股，成交量44.739万股，换手率1.57%，振幅9.38%。Castle Biosciences, Inc.股票所在的生命科学行业中，整体跌幅为0.98%。其相关个股中，Neuronetics, Inc.、Grail, Inc.、Opko健康涨幅较大，Ispecimen Inc.、Prophase Labs, Inc.、Neuronetics, Inc.较为活跃，换手率分别为16.91%、7.56%、7.06%，振幅较大的相关个股有Genedx Holdings Corp C/Wts 22/07/2026 、Bioaffinity Technologies, Inc.、Biodesix, Inc.，振幅分别为36.22%、34.15%、33.66%。Castle Biosciences, Inc.公司简介：Castle Biosciences Inc是一家商业阶段的皮肤癌公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025030503235396398941&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025030503235396398941&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["CSTL","BK4196"],"gpt_icon":0},{"id":"2514282320","title":"Castle Biosciences, Inc.盘中异动 早盘急速下跌7.24%报23.45美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2514282320","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2514282320?lang=zh_cn&edition=full","pubTime":"2025-02-28 22:32","pubTimestamp":1740753126,"startTime":"0","endTime":"0","summary":"北京时间2025年02月28日22时32分，Castle Biosciences, Inc.股票出现异动，股价大幅下跌7.24%。截至发稿，该股报23.45美元/股，成交量1.0393万股，换手率0.04%，振幅2.65%。Castle Biosciences, Inc.股票所在的生命科学行业中，整体涨幅为0.64%。其相关个股中，Oncocyte Corporation、Opko健康、Biodesix, Inc.涨幅较大，Ispecimen Inc.、Mainz Biomed N.V.、Prophase Labs, Inc.较为活跃，换手率分别为4.28%、0.84%、0.75%，振幅较大的相关个股有Radnet, Inc.、Aclaris Therapeutics, Inc.、Sotera Health Company，振幅分别为8.75%、5.13%、4.64%。Castle Biosciences, Inc.公司简介：Castle Biosciences Inc是一家商业阶段的皮肤癌公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250228223206a2580142&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250228223206a2580142&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4196","CSTL"],"gpt_icon":0},{"id":"2514270363","title":"Baird：维持Castle Biosciences(CSTL.US)评级，由优于大市调整至优于大市评级, 目标价由36.00美元调整至37.00美元。","url":"https://stock-news.laohu8.com/highlight/detail?id=2514270363","media":"金融界","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2514270363?lang=zh_cn&edition=full","pubTime":"2025-02-28 22:28","pubTimestamp":1740752881,"startTime":"0","endTime":"0","summary":"Baird：维持Castle Biosciences(CSTL.US)评级，由优于大市调整至优于大市评级, 目标价由36.00美元调整至37.00美元。","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://24h.jrj.com.cn/2025/02/28222848467016.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"jinrongjie_stock","symbols":["CSTL"],"gpt_icon":0},{"id":"1100923571","title":"Castle Biosciences 2024年第四季度GAAP每股收益为$0.32，同比增涨，销售额为$86.311M，超出$81.911M预期","url":"https://stock-news.laohu8.com/highlight/detail?id=1100923571","media":"财报速递","labels":["express"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1100923571?lang=zh_cn&edition=full","pubTime":"2025-02-28 05:23","pubTimestamp":1740691404,"startTime":"0","endTime":"0","summary":"Castle Biosciences报告季度每股收益为$0.32。这相较于去年同期的每股亏损$，增长了420%。公司报告季度销售额为$86.311百万，超出分析师的预期$81.911百万，超出5.37%。这比去年同期的销售额$66.120百万增长了30.54%。以上内容来自Benzinga Earnings专栏，原文如下：Castle Biosciences  reported quarterly earnings of $0.32 per share. This is a 420 percent increase over losses of $ per share from the same period last year.  The company reported quarterly sales of $86.311 million which beat the analyst consensus estimate of $81.911 million by 5.37 percent.  This is a 30.54 percent increase over sales ","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":"Castle Biosciences 2024年第四季度GAAP每股收益为$0.32，同比增涨，销售额为$86.311M，超出$81.911M预期","news_tag":"express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["CSTL"],"gpt_icon":0},{"id":"2514286857","title":"Castle Biosciences, Inc.盘中异动 临近午盘股价大涨5.00%","url":"https://stock-news.laohu8.com/highlight/detail?id=2514286857","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2514286857?lang=zh_cn&edition=full","pubTime":"2025-02-27 00:43","pubTimestamp":1740588221,"startTime":"0","endTime":"0","summary":"北京时间2025年02月27日00时43分，Castle Biosciences, Inc.股票出现波动，股价快速上涨5.00%。Castle Biosciences, Inc.股票所在的生命科学行业中，整体跌幅为0.11%。其相关个股中，Veracyte, Inc.、Grail, Inc.、Neuronetics, Inc.涨幅较大，Prophase Labs, Inc.、Ispecimen Inc.、Mainz Biomed N.V.较为活跃，换手率分别为10.23%、8.22%、5.18%，振幅较大的相关个股有Bioaffinity Technologies Inc C/Wts 07/09/2027 、Genedx Holdings Corp C/Wts 22/07/2026 、Prophase Labs, Inc.，振幅分别为36.76%、28.66%、14.10%。Castle Biosciences, Inc.公司简介：Castle Biosciences Inc是一家商业阶段的皮肤癌公司。该公司的产品组合包括皮肤黑素瘤，DecisionDx-黑色素瘤，DecisionDx-CMSeq和DecisionDx-PRAME。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250227004341a255156d&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250227004341a255156d&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["CSTL","BK4196"],"gpt_icon":0},{"id":"2505216208","title":"Castle Biosciences, Inc.盘中异动 急速上涨5.05%报26.20美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2505216208","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2505216208?lang=zh_cn&edition=full","pubTime":"2025-01-21 23:25","pubTimestamp":1737473137,"startTime":"0","endTime":"0","summary":"北京时间2025年01月21日23时25分，Castle Biosciences, Inc.股票出现波动，股价急速上涨5.05%。截至发稿，该股报26.20美元/股，成交量7.354万股，换手率0.26%，振幅3.45%。Castle Biosciences, Inc.股票所在的生命科学行业中，整体涨幅为1.56%。其相关个股中，Guardant Health, Inc.、Grail, Inc.、Personalis, Inc.涨幅较大，Ispecimen Inc.、Applied Dna Sciences, Inc.、T2 Biosystems, Inc.较为活跃，换手率分别为18.36%、2.29%、1.99%，振幅较大的相关个股有Guardant Health, Inc.、安奈特保险、Neuronetics, Inc.，振幅分别为12.44%、10.76%、10.11%。Castle Biosciences, Inc.公司简介：Castle Biosciences Inc是一家商业阶段的皮肤癌公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250121232538986e3dbe&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250121232538986e3dbe&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4196","CSTL"],"gpt_icon":0},{"id":"2503570926","title":"Castle Biosciences, Inc.盘中异动 早盘快速下挫5.05%报24.83美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2503570926","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2503570926?lang=zh_cn&edition=full","pubTime":"2025-01-14 23:35","pubTimestamp":1736868956,"startTime":"0","endTime":"0","summary":"北京时间2025年01月14日23时35分，Castle Biosciences, Inc.股票出现波动，股价快速下挫5.05%。截至发稿，该股报24.83美元/股，成交量18.0555万股，换手率0.64%，振幅6.12%。Castle Biosciences, Inc.股票所在的生命科学行业中，整体跌幅为0.19%。其相关个股中，Atlantic International Corp.、Oncocyte Corporation、Precipio, Inc.涨幅较大，Ispecimen Inc.、Precipio, Inc.、Neuronetics, Inc.较为活跃，换手率分别为2.11%、1.45%、1.37%，振幅较大的相关个股有Neuronetics, Inc.、T2 Biosystems, Inc.、Atlantic International Corp.，振幅分别为11.92%、10.63%、9.67%。Castle Biosciences, Inc.公司简介：Castle Biosciences Inc是一家商业阶段的皮肤癌公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025011423355696038b7a&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025011423355696038b7a&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["CSTL","BK4196"],"gpt_icon":0},{"id":"2503458680","title":"Castle Biosciences, Inc.盘中异动 早盘股价大跌8.03%","url":"https://stock-news.laohu8.com/highlight/detail?id=2503458680","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2503458680?lang=zh_cn&edition=full","pubTime":"2025-01-13 22:32","pubTimestamp":1736778726,"startTime":"0","endTime":"0","summary":"北京时间2025年01月13日22时32分，Castle Biosciences, Inc.股票出现异动，股价急速下挫8.03%。Castle Biosciences, Inc.股票所在的生命科学行业中，整体涨幅为0.08%。其相关个股中，Neuronetics, Inc.、Atlantic International Corp.、Caredx, Inc.涨幅较大，Bioaffinity Technologies, Inc.、Applied Dna Sciences, Inc.、Ispecimen Inc.较为活跃，换手率分别为17.51%、0.61%、0.51%，振幅较大的相关个股有Exagen Inc.、Neuronetics, Inc.、Castle Biosciences, Inc.，振幅分别为104.11%、16.37%、6.88%。Castle Biosciences, Inc.公司简介：Castle Biosciences Inc是一家商业阶段的皮肤癌公司。该公司的产品组合包括皮肤黑素瘤，DecisionDx-黑色素瘤，DecisionDx-CMSeq和DecisionDx-PRAME。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250113223207960252df&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250113223207960252df&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4196","CSTL"],"gpt_icon":0},{"id":"2502867527","title":"Castle Biosciences, Inc.盘中异动 早盘急速下挫5.20%","url":"https://stock-news.laohu8.com/highlight/detail?id=2502867527","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2502867527?lang=zh_cn&edition=full","pubTime":"2025-01-10 22:32","pubTimestamp":1736519543,"startTime":"0","endTime":"0","summary":"北京时间2025年01月10日22时32分，Castle Biosciences, Inc.股票出现波动，股价急速跳水5.20%。Castle Biosciences, Inc.股票所在的生命科学行业中，整体跌幅为0.52%。其相关个股中，Mainz Biomed N.V.、Neuronetics, Inc.、燃石医学涨幅较大，Applied Dna Sciences, Inc.、Mainz Biomed N.V.、T2 Biosystems, Inc.较为活跃，换手率分别为1.75%、0.63%、0.38%，振幅较大的相关个股有Check-Cap Ltd.、Biodesix, Inc.、Prophase Labs, Inc.，振幅分别为5.10%、4.11%、3.90%。Castle Biosciences, Inc.公司简介：Castle Biosciences Inc是一家商业阶段的皮肤癌公司。该公司的产品组合包括皮肤黑素瘤，DecisionDx-黑色素瘤，DecisionDx-CMSeq和DecisionDx-PRAME。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250110223223aba602c6&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250110223223aba602c6&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["CSTL","BK4196"],"gpt_icon":0}],"profile":{"websiteUrl":"http://www.castlebiosciences.com","stockEarnings":[{"period":"1week","weight":-0.0575},{"period":"1month","weight":-0.2096},{"period":"3month","weight":-0.3383},{"period":"6month","weight":0.1933},{"period":"1year","weight":0.3625},{"period":"ytd","weight":-0.3429}],"compareEarnings":[{"period":"1week","weight":-0.015},{"period":"1month","weight":-0.0429},{"period":"3month","weight":-0.0286},{"period":"6month","weight":0.0074},{"period":"1year","weight":0.2011},{"period":"ytd","weight":-0.0288}],"compareStock":{"symbol":"SPY","name":"标普500ETF"},"description":"Castle Biosciences, Inc.于2007年9月12日在特拉华州注册成立。该公司是一家商业阶段的皮肤病癌症公司，致力于为医生及其患者提供个性化，临床可操作的基因组信息，以做出更准确的治疗决策。","yearOnYearQuotes":[{"month":1,"riseRate":0.714286,"avgChangeRate":0.02781},{"month":2,"riseRate":0.285714,"avgChangeRate":-0.094275},{"month":3,"riseRate":0.285714,"avgChangeRate":-0.021663},{"month":4,"riseRate":0.5,"avgChangeRate":-0.084405},{"month":5,"riseRate":0.5,"avgChangeRate":0.014411},{"month":6,"riseRate":0.333333,"avgChangeRate":-0.00564},{"month":7,"riseRate":0.666667,"avgChangeRate":0.055356},{"month":8,"riseRate":1,"avgChangeRate":0.247828},{"month":9,"riseRate":0.142857,"avgChangeRate":-0.100564},{"month":10,"riseRate":0.428571,"avgChangeRate":0.054309},{"month":11,"riseRate":0.571429,"avgChangeRate":0.067915},{"month":12,"riseRate":0.571429,"avgChangeRate":0.093813}],"exchange":"NASDAQ","name":"Castle Biosciences, Inc.","nameEN":"Castle Biosciences, Inc."},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"tenantId":"TBCN","deviceId":"web-server-community-laohu8-v3","version":"4.36.2","shortVersion":"4.36.2","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"Castle Biosciences, Inc.(CSTL)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供Castle Biosciences, Inc.(CSTL)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"Castle Biosciences, Inc.,CSTL,Castle Biosciences, Inc.股票,Castle Biosciences, Inc.股票老虎,Castle Biosciences, Inc.股票老虎国际,Castle Biosciences, Inc.行情,Castle Biosciences, Inc.股票行情,Castle Biosciences, Inc.股价,Castle Biosciences, Inc.股市,Castle Biosciences, Inc.股票价格,Castle Biosciences, Inc.股票交易,Castle Biosciences, Inc.股票购买,Castle Biosciences, Inc.股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"Castle Biosciences, Inc.(CSTL)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供Castle Biosciences, Inc.(CSTL)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}